Effectiveness and duration of protection of primary and booster immunisation against meningococcal serogroup C disease with meningococcal conjugate C and ACWY vaccines: Systematic review.

Matas GriskaitisIris ThielemannViktoria SchönfeldAnnika FalmanStefan ScholzUlrich ReinacherLaura HaasOle WichmannThomas Harder

Published in: The Journal of infection (2024)

A single dose of MenC or MenACWY vaccine at 12-23 months of age provides robust protection against MenC IMD. Data on booster immunisation are sparse, but indicate prolonged protection for three years at least.

Keyphrases

systematic review
meta analyses
randomized controlled trial
electronic health record
neural network